Indobufen
From Wikipedia, the free encyclopedia
|
Indobufen
|
|
| Systematic (IUPAC) name | |
| 2-(4-(1-oxoisoindolin-2-yl)phenyl)butanoic acid | |
| Identifiers | |
| CAS number | |
| ATC code | B01 |
| PubChem | |
| Chemical data | |
| Formula | C18H17NO3 |
| Mol. mass | 295.333 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
Indobufen is a platelet aggregation inhibitor.
[edit] References
- The Merck Index, 12th Edition. 4991
|
||||||||||||||||||||||||||

